BioCentury | Nov 3, 2017
Financial News

BioArctic prices SSE IPO

...SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie Investment Bank AB and the DNB Markets...
BioCentury | Apr 24, 2017
Clinical News

Wilson upgraded after final Phase II copper readout

...bis-choline tetrathiomolybdate (WTX101) to treat Wilson's disease, in which excess copper accumulates in the body. DNB Markets...
BioCentury | Apr 14, 2017
Financial News

BerGenBio completes IPO

...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and DNB markets...
BioCentury | Apr 6, 2017
Financial News

BerGenBio set to trade after Oslo IPO

...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and DNB markets...
BioCentury | Mar 10, 2017
Financial News

BerGenBio proposes IPO

...launch an IPO on the Oslo exchange underwritten by ABG Sundal Collier, Arctic Securities and DNB Markets...
BioCentury | Mar 8, 2017
Financial News

BerGenBio planning Oslo IPO

...said it plans to launch an IPO underwritten by ABG Sundal Collier, Arctic Securities and DNB Markets...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides raises SEK650M in IPO

...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB Markets...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides completes IPO

...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB Markets...
BioCentury | Dec 9, 2016
Financial News

Nordic Nanovector completes private placement

...$59.2 million) through the sale of 4.4 million shares at NOK114 in a private placement. DNB Markets...
BioCentury | Dec 9, 2016
Financial News

Zimmer Biomet completes private placement of senior notes

...RBC Capital Markets, Mitsubishi UFJ Financial Group, Wells Fargo, BMO Capital Markets, Citigroup, Credit Suisse, DNB Markets...
Items per page:
1 - 10 of 37
BioCentury | Nov 3, 2017
Financial News

BioArctic prices SSE IPO

...SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie Investment Bank AB and the DNB Markets...
BioCentury | Apr 24, 2017
Clinical News

Wilson upgraded after final Phase II copper readout

...bis-choline tetrathiomolybdate (WTX101) to treat Wilson's disease, in which excess copper accumulates in the body. DNB Markets...
BioCentury | Apr 14, 2017
Financial News

BerGenBio completes IPO

...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and DNB markets...
BioCentury | Apr 6, 2017
Financial News

BerGenBio set to trade after Oslo IPO

...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and DNB markets...
BioCentury | Mar 10, 2017
Financial News

BerGenBio proposes IPO

...launch an IPO on the Oslo exchange underwritten by ABG Sundal Collier, Arctic Securities and DNB Markets...
BioCentury | Mar 8, 2017
Financial News

BerGenBio planning Oslo IPO

...said it plans to launch an IPO underwritten by ABG Sundal Collier, Arctic Securities and DNB Markets...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides raises SEK650M in IPO

...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB Markets...
BioCentury | Feb 24, 2017
Financial News

Oncopeptides completes IPO

...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB Markets...
BioCentury | Dec 9, 2016
Financial News

Nordic Nanovector completes private placement

...$59.2 million) through the sale of 4.4 million shares at NOK114 in a private placement. DNB Markets...
BioCentury | Dec 9, 2016
Financial News

Zimmer Biomet completes private placement of senior notes

...RBC Capital Markets, Mitsubishi UFJ Financial Group, Wells Fargo, BMO Capital Markets, Citigroup, Credit Suisse, DNB Markets...
Items per page:
1 - 10 of 37